Related Experiment Video
Updated: Jun 12, 2026
08:56
Kinetic Measurement and Real Time Visualization of Somatic Reprogramming
Published on: July 30, 2016
Overseeing innovative therapy without mistaking it for research: a function-based model based on old truths, new
1Children's Hospital Boston, USA.
Summary
Innovative therapy oversight needs a new model. Revisiting the Belmont Report principles and considering current human embryonic stem cell risks suggests a context-specific approach balancing safety and quality systems.
Area of Science:
- Bioethics
- Stem Cell Research
- Health Policy
Background:
- Current human embryonic stem cell (hESC) clinical applications raise safety concerns.
- This necessitates re-evaluating ethical oversight for innovative therapies.
- Existing frameworks may not adequately address novel therapeutic risks.
Purpose of the Study:
- To re-examine the ethical principles outlined in the Belmont Report.
- To propose a new model for overseeing innovative therapies.
- To incorporate current advancements and risks in hESC research.
Main Methods:
- Review of foundational ethical documents, including those informing the Belmont Report.
- Analysis of contemporary challenges in human embryonic stem cell clinical applications.
- Development of a risk-based, context-specific oversight model.
Main Results:
- The Belmont Report's principles remain relevant but require adaptation.
- A new oversight model is proposed, distinct from traditional research paradigms.
- The model emphasizes safety and quality systems within healthcare settings.
Conclusions:
- Innovative therapy oversight requires a nuanced, risk-based approach.
- A revised ethical framework is needed to accommodate advancements in regenerative medicine.
- Integrating safety and quality systems is crucial for responsible clinical innovation.
More Related Videos
12:38Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies
Published on: July 19, 2007
11:42In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes
Published on: June 10, 2021
Related Concept Videos
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:28Forced Transdifferentiation
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...
Artificial transdifferentiation occurs...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...